Innovation and Industry Strength Recognized at CPhI

Using the annual CPhI Worldwide tradeshow as a benchmark, the bio/pharma industry appears to be healthy and growing. Organizers of the 2018 event, held Oct. 9–11 in Madrid, Spain, reported attendance has increased by 9000 attendees compared with the last CPhI event in Madrid in 2015. Nearly 44,500 participants from 164 countries visited the three-day event, which included more than 2,500 exhibits, conference sessions, and networking opportunities (1).

Opinions about industry prospects around the globe also were revealed. In an annual study released during the event (2), CPhI reported results of a survey of bio/pharma professionals that ranked India, the United States, and China as the top regions for predicted pharma market growth. The US ranked first of 10 countries evaluated for reputation, followed by Germany, Japan, the United Kingdom, and France. India was ranked sixth; China was ranked last.

CPhI also measured perceptions of the knowledge of bioprocessing professionals, innovation, and quality with the US ranking first, followed again by Germany, Japan, and the UK. In a measure of growth potential, Ireland-home to planned expansions of bioprocessing capacity-ranked third.

Recognizing innovation

In addition to the industry data, innovative technologies and services that support bio/pharma development, manufacturing, and distribution were recognized at the 2018 CPhI Pharma Awards Gala, held on Oct. 9, 2018.

The winners were selected from 139 finalists in 17 categories including drug formulation, manufacturing, materials, packaging, drug delivery, patient compliance, contract services, pharma company of the year, and CEO of the year. The finalists were selected from more than 250 entries. The winners are as follows:

• API Development-Ipca Labs Limited, Atemisinin

• Formulation-MiVital AG, Micelle Inside Solubilization

• Excipients-Merck, Parteck MXP Excipient

• Manufacturing Technology/Equipment- AqVida, AqVida filling line

• Bioprocessing and Manufacturing-Merck, Simplification of Fed Batch Processes Using Modified Amino Acids

• Analysis, Testing, and Quality Control-Tornado Spectral Systems, HyperFlux PRO Plus, Tornado Spectral Systems

• Drug Delivery Devices-Nemera , e-NOVELIA, smart ophthalmic add-on. Highly commended: Stiplastics, Stiplastics

• Contract Services and Outsourcing- CatSci Ltd, Development of a novel bio-catalyzed manufacturing route for a generic API. Highly commended: Cambrex, Continuous Flow Centre of Excellence

• Packaging-Technoflex, Dual-Mix. Highly commended: Aptar Pharma, QuickFlip

• Supply Chain, Logistics, and Distribution-Systech International, UniSecure

• Regulatory Procedures and Compliance-Scientist.com

• Corporate Social Responsibility-West Pharmaceutical Services, Inc., Delivering on the Promise of Good Corporate Citizenship

• CEO of the Year-Nanobiotix, Laurent Levy

• Pharma Company of the Year-Nanobiotix

• OTC-Medical Brands and Vemedia, Excilor 2-in-1 Wart Treatment Device

• Patient Centricity-SRS Life Sciences Pte Ltd, SRS Unistraw Delivery System

• IT, mHealth, and Digitalization-Qualit-e Cloud GmbH, Qualit-e Cloud

Job well done

Congratulations to the awards finalists and winners. Information about select winning technologies will be published in future issues of Pharmaceutical Technology and on www. PharmTech.com.

CPhI and Pharmaceutical Technology are UBM (part of Informa plc) brands.

References

1. CPhI, “Global pharma set for strong year with record 164 countries and 44,500 attendees at CPhI Worldwide,” Press Release, Oct. 22, 2018.
2. CPhI, “CPhI’s Pharma Industry Rankings: A Snapshot of Pharma’s Health,” CPhI Annual Industry Report, October 2018.

Article Details

Pharmaceutical Technology
Vol. 42, No. 11
November 2018
Page: 10

Citation

When referring to this article, please cite it as R. Peters, " Innovation and Industry Strength Recognized at CPhI," Pharmaceutical Technology 42 (11) 2018.